arctiin has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Chen, P; He, J; Kenny, J; Kuek, V; Liu, Y; Qiu, H; Wang, C; Wang, G; Wang, H; Wang, J; Wang, Q; Wang, Z; Xu, J; Yang, F; Ye, Z; Yuan, J; Zhang, G; Zhang, M | 1 |
1 other study(ies) available for arctiin and Bone Loss, Osteoclastic
Article | Year |
---|---|
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
Topics: Animals; Antioxidant Response Elements; Bone Density Conservation Agents; Bone Resorption; Calcium Signaling; Disease Models, Animal; Female; Furans; Glucosides; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; RAW 264.7 Cells; Reactive Oxygen Species | 2020 |